Literature DB >> 7726612

Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome.

T J Neuhaus1, J Fay, M J Dillon, R S Trompeter, T M Barratt.   

Abstract

A review was undertaken of the use of alternative immunosuppressive treatment in addition to corticosteroids in a cohort of 429 children with steroid sensitive nephrotic syndrome (SSNS) treated between 1980 and 1994. Two hundred and twenty two children (52%) received at least one course of alternative treatment, 98 (23%) two, and 43 (10%) three. Cyclophosphamide was administered to 196 children (46%); in 181 it was the first course of alternative treatment and in 104 (57%) of those it was also the last ('final course'). Levamisole was given to 56 children (13%) and cyclosporin to 53 (12%). Fifteen children in whom cyclosporin failed were treated with chlorambucil. A few patients received azathioprine or vincristine. Ten children developed secondary steroid resistance, of whom five progressed to chronic renal failure. Acute complications included reversible renal failure, septicaemia, peritonitis, convulsions, and cerebral thrombosis. There were three deaths. It is concluded that half of the referred children with SSNS were deemed to require at least one course of alternative immunosuppressive treatment, and that side effects of the treatment and complications of SSNS are infrequent but occasionally fatal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7726612      PMCID: PMC1030089          DOI: 10.1136/adc.71.6.522

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  25 in total

1.  Peritonitis in children with nephrotic syndrome.

Authors:  M J Gorensek; M H Lebel; J D Nelson
Journal:  Pediatrics       Date:  1988-06       Impact factor: 7.124

2.  Outcome of childhood minimal-change disease.

Authors:  H M Coovadia; M Adhikari
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

3.  Nephrotic syndrome: from toddlers to twenties.

Authors:  E Ingulli; R Gonzalez; D Rajpoot; A Tejani
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

4.  Pituitary-gonadal function in women following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study.

Authors:  R Bogdanović; M Banićević; A Cvorić
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

5.  Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study.

Authors:  R Bogdanović; M Banićević; A Cvorić
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

6.  Nephrotic syndrome: from toddlers to twenties.

Authors:  M A Lewis; E M Baildom; N Davis; I B Houston; R J Postlethwaite
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

7.  Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  J Brodehl; M Brandis; U Helmchen; P F Hoyer; R Burghard; J H Ehrich; R B Zimmerhackl; W Klein; K Wonigeit
Journal:  Klin Wochenschr       Date:  1988-11-15

8.  Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults.

Authors:  O Mehls; K Andrassy; J Koderisch; U Herzog; E Ritz
Journal:  J Pediatr       Date:  1987-06       Impact factor: 4.406

9.  Thromboembolic complications in children with nephrotic syndrome. Risk and incidence.

Authors:  P F Hoyer; S Gonda; M Barthels; H P Krohn; J Brodehl
Journal:  Acta Paediatr Scand       Date:  1986-09

10.  High incidence of minimal change nephrotic syndrome in Asians.

Authors:  J Feehally; N P Kendell; P G Swift; J Walls
Journal:  Arch Dis Child       Date:  1985-11       Impact factor: 3.791

View more
  15 in total

1.  Cerebral sinus thrombosis in a child with steroid-resistant nephrotic syndrome.

Authors:  Jean-Bernard Palcoux; François Gaspard; Denis Campagne
Journal:  Pediatr Nephrol       Date:  2003-04-05       Impact factor: 3.714

Review 2.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

Review 3.  Treatment of steroid sensitive nephrotic syndrome.

Authors:  A S Abeyagunawardena
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

4.  Nitrogen mustard therapy and nephrotic syndrome.

Authors:  R Arumugam; A R Watson
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

5.  Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome.

Authors:  Ahmet Taner Elmas; Yılmaz Tabel; Ozlem Nalbantoğlu Elmas
Journal:  Int Urol Nephrol       Date:  2012-07-24       Impact factor: 2.370

6.  LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile.

Authors:  Tarak Srivastava; Mukut Sharma; Kok-Hooi Yew; Ram Sharma; R Scott Duncan; Moin A Saleem; Ellen T McCarthy; Alexander Kats; Patricia A Cudmore; Uri S Alon; Christopher J Harrison
Journal:  J Cell Commun Signal       Date:  2012-11-17       Impact factor: 5.782

Review 7.  Is rituximab effective in childhood nephrotic syndrome? Yes and no.

Authors:  Markus J Kemper; Anja Lehnhardt; Anna Zawischa; Jun Oh
Journal:  Pediatr Nephrol       Date:  2013-07-03       Impact factor: 3.714

8.  Long-term effects of levamisole treatment in childhood nephrotic syndrome.

Authors:  Viktória Sümegi; Ibolya Haszon; Béla Iványi; Csaba Bereczki; Ferenc Papp; Sándor Túri
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

9.  The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome.

Authors:  Asiri S Abeyagunawardena; Michael J Dillon; Lesley Rees; William van't Hoff; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

10.  Clinical course and NPHS2 analysis in patients with late steroid-resistant nephrotic syndrome.

Authors:  Peter Schwaderer; Tanja Knüppel; Martin Konrad; Otto Mehls; Karl Schärer; Franz Schaefer; Stefanie Weber
Journal:  Pediatr Nephrol       Date:  2007-11-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.